The evidence for an association between hypertensive disease, elevated admission arterial pressure, and perioperative cardiac outcome is reviewed. A systematic review and meta-analysis of 30 observational studies demonstrated an odds ratio for the association between hypertensive disease and perioperative cardiac outcomes of 1.35 (1.17±1.56). This association is statistically but not clinically signi®cant. There is little evidence for an association between admission arterial pressures of less than 180 mm Hg systolic or 110 mm Hg diastolic and perioperative complications. The position is less clear in patients with admission arterial pressures above this level. Such patients are more prone to perioperative ischaemia, arrhythmias, and cardiovascular lability, but there is no clear evidence that deferring anaesthesia and surgery in such patients reduces perioperative risk. We recommend that anaesthesia and surgery should not be cancelled on the grounds of elevated preoperative arterial pressure. The intraoperative arterial pressure should be maintained within 20% of the best estimate of preoperative arterial pressure, especially in patients with markedly elevated preoperative pressures. As a result, attention should be paid to the presence of target organ damage, such as coronary artery disease, and this should be taken into account in preoperative risk evaluation. The anaesthetist should be aware of the potential errors in arterial pressure measurements and the impact of white coat hypertension on them. A number of measurements of arterial pressure, obtained by competent staff (ideally nursing staff), may be required to obtain an estimate of the`true' preoperative arterial pressure.
The importance of hypertension
The association between elevated arterial pressure and cardiovascular disease is unequivocally established and well known to doctors and the general public. The risk of cardiovascular events in the general population increases steadily with increases in arterial pressure. The individuals at greatest risk of suffering a cardiovascular event because of hypertension are those with the highest arterial pressures. However, mild to moderate hypertension is more common than severe hypertension, and much of the population burden of disease because of hypertension may be attributed to moderate rather than severe hypertension. This is illustrated in Figure 1 , which documents the association between systolic hypertension and deaths as a result of coronary artery disease. 74 The highest risk of death is seen in patients with systolic arterial pressures of greater than 180 mm Hg. However, the greatest number of excess deaths (calculated as the difference between the number of deaths that would be expected from coronary artery disease on the basis of the rate in the group with a systolic arterial pressure of less than 110 mm Hg and the number of deaths actually recorded) is seen in the largest group of subjects. That is, those with systolic arterial pressures of between 140 and 149 mm Hg. Hence, medical guidelines for the treatment of hypertension emphasize the treatment of mild to moderate hypertension. The British Hypertension Society Guidelines on the management of hypertension use a threshold of 140/ 90 mm Hg for the initiation of treatment. 63 This review will suggest that, while these guidelines are appropriate for the medical management of hypertension, the cut-offs that they use are overly demanding for the management of hypertension in the perioperative setting.
Historical background
Sprague ®rst identi®ed an association between hypertension and perioperative cardiac risk in 1929. He described a series of 75 hypertensive patients of whom one-third died in the perioperative period; 12 of these had cardiovascular complications. 71 The introduction of antihypertensive drugs led to concerns that patients on such drugs might be at increased risk of perioperative cardiac lability. In 1966, Dingle recommended that patients presenting for anaesthesia and surgery should, if possible, undergo autonomic testing before their operation. This would give some indication of their risk of cardiac lability and whether or not their antihypertensive therapy should be continued.
14 These recommendations were overtaken by the work of Prys-Roberts and colleagues, who published a series of studies on the interaction between hypertension and anaesthesia. The ®rst of these studies examined a small group of 34 patients undergoing anaesthesia and elective surgery. 62 Fifteen of the patients were classi®ed as normotensive, although by current standards all of their control patients would now be considered hypertensive. The remainder of the patients were classi®ed as treated or untreated hypertensives. By current standards, these patients would probably be considered to have severe hypertension as several were reported as having systolic arterial pressures of 220±230 mm Hg. The patients underwent intensive haemodynamic monitoring. The authors reported that the untreated hypertensive patients had a greater decrease in arterial pressure at induction of anaesthesia and that they were more prone to intraoperative myocardial ischaemia. There were no adverse events reported in either the control or hypertensive groups.
On the basis of these ®ndings the authors recommended that, where possible, hypertensive patients should have anaesthesia and surgery deferred to allow their hypertension to be treated. This recommendation led to a major change in anaesthetic practice, and to the modern perception that where possible untreated hypertensives should not be subjected to elective anaesthesia and surgery without ®rst treating their arterial pressure. However, these recommendations should be applied with some caution. The perception of what constitutes hypertension has changed considerably since these studies were undertaken. Arterial pressures that in the early 1970s would have been considered acceptable are today consistent with levels of hypertension where treatment is obligatory. As already stated, all of the control patients in the study by PrysRoberts and colleagues would now be considered to be hypertensive. The recommendations of Prys-Roberts and colleagues therefore need to be reconsidered in the light of the modern views of hypertension and its management.
The classi®cation of hypertension
It has been indicated above that raised arterial pressure is associated with a continuum of risk, with greatest risk associated with the highest arterial pressures. For the purposes of analysis, discussion and treatment recommendations, it is necessary to grade and classify raised arterial pressure in some way or another. This may be done implicitly by de®ning treatment thresholds, as in the British Hypertension Society guidelines, or explicitly, by dividing arterial pressure into bands of increasingly severe hypertension, as in the classi®cation of the Sixth Joint National Committee on the Detection, Evaluation and Treatment of High Blood Pressure (JNC VI). 35 However, it has been pointed out that the differences between classi®cations can have major implications for estimating the prevalence of hypertension and the number of people in a population who may require treatment. The World Hypertension Society/ International Society of Hypertension (WHO/ISH) guidelines set lower thresholds than those advocated by either the British Hypertension Society or JNC VI. Acceptance of the WHO/ISH thresholds results in 45% of the population as a whole and 60% of the adult population being classi®ed as hypertensive. 51 It is important to remember the ultimate goals in the treatment of hypertension. These are the reduction of the risk of cardiovascular events for the individual patient and in the population as a whole. Hypertension is only one of a number of risk factors for cardiovascular disease and a number of guidelines, including those issued by the British Hypertension Society, advocate treatment not on the basis of arterial pressure alone but according to the overall estimate of cardiovascular risk (Fig. 2) . 63 
Fig 1
The effect of systolic pressure at entry to MRFIT (Multiple Risk Factor Intervention Trial) on the relative risk of death because of coronary artery disease. The number of excess deaths is calculated relative to the number of deaths because of coronary artery disease that would be expected from the death rate in the baseline group, that is those patients with a systolic arterial pressure of less than 110 mm Hg. 74 For the purposes of this review, the classi®cation of hypertension described in JNC VI will be followed (Table 1) . 35 This classi®cation is based solely on arterial pressure readings and does not take into account other risk factors, although the importance of taking these into account when deciding on treatment is highlighted. It de®nes bands for both systolic and diastolic pressure. Where a patient's systolic and diastolic arterial pressures fall into two different categories, the higher category is selected. It offers a graded classi®cation with six bands of arterial pressure and acknowledges that levels of arterial pressure above optimal pressures of less than 120/80 mm Hg carry some increased risk, while not leading us to classify a large proportion of the population as hypertensive. The anaesthetist is often called upon to take a view on whether or not a given level of arterial pressure is clinically important. The JNC VI classi®cation allows us to identify the place of an individual patient's arterial pressure on a scale of increasing severity. It does, however, have some limitations when applied to the patient presenting for surgery. The most important is that the classi®cation of hypertension is based on the average of two or more readings of arterial pressure taken at two or more visits after initial screening. However, in current British practice, it is uncommon for the anaesthetist to have the bene®t of arterial pressure readings taken on a number of recent occasions.
De®ning the questions
The perioperative management of hypertensive patients is a complex issue that can be divided into a number of different questions.
1. Is having a diagnosis of hypertension of itself associated with increased perioperative risk, regardless of the arterial pressure at the time of admission to hospital for surgery?
2. Is elevated arterial pressure at the time of admission for surgery associated with increased perioperative cardiac risk?
3. What is the importance, if any, of poorly controlled hypertension in the perioperative setting? Is there any interaction between elevated admission arterial pressure and being diagnosed with hypertensive disease previously such that this increases perioperative risk?
4. Does the treatment of elevated admission arterial pressure before surgery reduce perioperative cardiac risk?
For the purposes of this review the term`hypertensive patient' refers to anyone who has been labelled a hypertensive: that is, someone for whom interventions to lower persistently raised arterial pressure would be appropriate, or someone who is already on treatment for hypertension. Raised arterial pressure will be described as such.
The core of this review will be an examination of the available observational studies that address the ®rst three questions and a discussion of the issues surrounding the interpretation of these studies. Related issues including arterial pressure measurement, white coat hypertension, the use of ambulatory arterial pressure monitoring, and perioperative arterial pressure lability will also be discussed. Recommendations will be offered for the perioperative management of hypertensive patients, although these are based only on observational data. It should be stated at the outset that the authors know of no randomized controlled trial that addresses the ®nal question. The practice of deferring elective surgery to allow poorly controlled arterial pressure to be treated is solely based on the perception that such elevated pressure is associated with increased perioperative risk, and therefore reducing the arterial pressure must be a good thing to do. There is no level one evidence to support this approach. 76 
Hypertensive disease and anaesthesia
This section presents a meta-analysis of observational studies examining the association between hypertension and perioperative cardiac risk in patients undergoing noncardiac surgery. Papers were identi®ed as relevant to the association between hypertension and perioperative cardiovascular outcome if published between 1971 and the end of 2001. The former date was chosen as the lower cutoff year, because this was the year in which the paper Studies of anaesthesia in relation to hypertension. I. Cardiovascular responses of treated and untreated patients' was published. 62 The MEDLINE database was interrogated using the following combinations of search terms: {anaes-thesia OR anesthesia} AND cardiac risk; {anaesthesia OR anesthesia} AND cardiovascular risk; hypertension AND postoperative complication AND adult NOT animal; hypertension AND intraoperative complication AND adult NOT animal; arterial pressure AND postoperative complication AND adult NOT animal; arterial pressure AND intraoperative complication AND adult NOT animal; preoperative risk strati®cation.
All searches were limited to articles in English. The abstracts of the papers identi®ed were scanned`on-line' to identify relevant papers. The reference lists of those papers that were identi®ed for inclusion in the meta-analysis were also scanned to identify further relevant studies.
The papers identi®ed from these searches were read in full. Those that included data concerning the association between hypertensive disease and perioperative cardiovascular complications were identi®ed. Reports were included if they examined outcomes considered to be major cardiovascular complications occurring up to 30 days after anaesthesia and surgery. Major cardiovascular complications were considered to be cardiovascular death, myocardial infarction, new or more severe angina, heart failure, life-threatening arrhythmias, and cerebrovascular accident. Several studies examined`minor' complications such as perioperative bradycardia and tachycardia, and perioperative hypotension and hypertension, and more serious complications. Where it was impossible to separate information on major complications from data on all complications, both major and minor, the study was excluded. Studies that reported the association between hypertension and perioperative myocardial ischaemia detected on Holter monitoring but did not contain data on the association between hypertension and clinically evident events were excluded.
For a study to be included, it had to be possible to derive from the report the crude odds ratio for the association between hypertension and perioperative cardiovascular complications, together with the variance of that odds ratio. The ideal would have been to include the adjusted odds ratios in which allowance had been made for the effect of other confounding variables. In most instances, this was not available.
A number of relevant studies were not primarily designed to examine hypertension or other perioperative cardiovascular risk factors, but were studies of diagnostic tests for preoperative cardiovascular assessment or (in one case) of the value of actively warming the patient during surgery. We have included those studies where the report of the study included relevant data on the association between hypertension and perioperative cardiovascular complications.
A number of studies examining stroke after carotid endarterectomy have been excluded, as it is argued that these studies examined a particular complication in an exceptional population, and the ®ndings from such studies may not generalize to patients undergoing other types of surgery.
The main focus of this meta-analysis was the association between hypertensive disease and perioperative complications, rather than any association between admission arterial pressure and such complications. Consequently, studies that de®ned hypertension solely in terms of the level of admission arterial pressure were excluded. Studies were included where the de®nition of hypertension was not given in the report. For example, in the`Multi-Center Study of General Anesthesia', the anaesthetist was asked to indicate if the patient was hypertensive or not, but the de®nition of hypertension used is not given. 20 A total of 4691 citations were identi®ed from the MEDLINE database. From these, 128 potentially relevant studies were identi®ed from 126 reports. (The full list of 126 citations can be viewed in the version of this review published on the British Journal of Anaesthesia website at http://bja.oupjournals.org/.) For these 128 studies, the full reports were obtained and read in detail. Ninety-eight studies described in 97 reports were excluded from further analysis.
In 80 studies, including the two studies described in a single paper, an effect estimate for the association between hypertension and cardiac complications was not given and could not be derived from the publication. Three studies were excluded because they appeared to include patients who had been examined in another study already included in the meta-analysis. In each case, only one of the pair of papers concerned was included in the meta-analysis. 39 41 58 In six of the excluded studies, hypertension was de®ned in terms of the arterial pressure alone with no reference to hypertensive disease. In two studies, hypertension was de®ned as either an elevated admission arterial pressure or a history of treatment with antihypertensive medications and no indication was given of which patients fell into each category. In three of the excluded studies, no distinction was made between major cardiovascular complications such as perioperative myocardial infarction and minor complications such as intraoperative bradycardia. One study was excluded because preoperative coronary artery by-pass grafting and perioperative cardiac complications were Table 2 Studies included in the meta-analysis of hypertension and anaesthesia. Note that the odds ratios for the study by Sprung and colleagues 72 and the studies by Howell and colleagues 33 34 were derived from paired data grouped together as one outcome. Separate information was not given on the association between hypertension and perioperative complications. One study included data on 676 operations in 617 patients. No information was given on which patients underwent more than one procedure. It was felt that using data from this study could lead to an underestimate of the variance of the odds ratio for hypertension and the study was excluded from the meta-analysis.
(The full list of excluded studies can be viewed in the electronic version of this paper.) Initially, it was planned to restrict this review and metaanalysis to patients undergoing general anaesthesia. It rapidly became clear that this was not practical. In those papers containing useful data that also gave information on the type of anaesthesia used a signi®cant proportion of patients received regional or local anaesthesia. 3 A ®xed effects meta-analysis of the crude odds ratios from these studies for the association between hypertension and cardiovascular complications was performed using thè meta' command of Stata v7.0. The Forrest plot of the data is shown in Figure 3 . The pooled odds ratio from this analysis was 1.35 (1.17±1.56) P<0.001. However, the test for heterogeneity also achieved statistical signi®cance (Q=44.76, 29 df, P=0.031). (Heterogeneity represents the extent or magnitude of differences in treatment or exposure effects between different studies.) 52 The source of this heterogeneity was sought through a number of sensitivity analyses grouping the data by year of study (for example 1978±1990 and 1991±2001) , and by type of surgery. These analyses yielded little impact on the odds ratio and there remained considerable heterogeneity within the subgroups studied. Thus, the odds ratio of 1.31, while statistically signi®cant, is small and must be interpreted with considerable caution in this meta-analysis of heterogeneous observational studies, with no correction for confounding. In the context of a low perioperative event rate, this small odds ratio probably represents a clinically insigni®cant association between pre-existing hypertension and perioperative cardiac risk.
Pre-existing hypertension and target organ damage
The association between hypertension and end or target organ damage is well established. Hypertension is inextricably linked to ischaemic heart disease and heart failure, to cerebrovascular disease and to renal impairment. Both the British Hypertension Society Guidelines and the World Health Organisation-International Society of Hypertension Guidelines for the management of arterial hypertension highlight the importance of co-existing disease and cardiovascular risk factors in setting treatment thresholds. 12 63 In both sets of guidelines, the presence of target organ damage and other cardiovascular risk factors lead to lower treatment thresholds for raised arterial pressure.
Similar considerations apply in the perioperative setting. Many reviews have highlighted the associations between the sequelae of hypertension, such as heart failure and ischaemic heart disease, and perioperative complications. 9 15 The meta-analysis of observational studies described above suggested an association between a diagnosis of hypertension and increased perioperative cardiac risk. However, the odds ratio was small and the conclusion must be treated with some circumspection in the light of heterogeneity of the studies examined. This is not to dismiss the role of clinically evident target organ damage in increasing perioperative risk. A recent study by Lee and colleagues identi®ed ischaemic heart disease, heart failure, and renal failure as risk factors for perioperative cardiac complications. 42 In assessing perioperative risk of major cardiovascular complications, pre-existing hypertension per se may be of limited importance, but this does not grant the anaesthetist a licence to ignore the target organ damage caused by hypertension. Such damage may carry signi®cant risk and its importance should be assessed using guidelines such as those referenced above. 9 15 Admission arterial pressure and perioperative cardiac risk
The best-designed study in this area is that of Goldman and Caldera. 27 This examined a sub-population of patients who were studied in the production of the Goldman Risk Index. Patients were divided into ®ve groups. These were: normotensive patients, patients treated with diuretics, treated hypertensives whose arterial pressure was controlled, patients who were hypertensive despite treatment, and untreated hypertensives. No signi®cant differences in perioperative cardiac risk were found between the hypertensive patients and the remaining groups. However, although extremely well designed, this study lacked the statistical power to either con®rm or refute an association between hypertensive heart disease and perioperative cardiac risk. Other studies, such as those by Cooperman, Eerola, and Steen examined admission arterial pressure as one of a number of variables that may contribute to perioperative cardiac risk. However, these studies either lacked the statistical power to effectively examine hypertension as a risk factor, or gave only limited information on the impact of hypertension in the ®nal report of the study. 13 17 75 None of the studies described above examined admission arterial pressure as a continuous variable. All have taken a speci®c cut-off for arterial pressure. The only studies of which the authors are aware that have examined arterial pressure as a continuous variable are those by Howell and colleagues. 33 34 The ®rst was a retrospective case controlled study which examined patients who died of a cardiac cause within 30 days of anaesthesia and elective surgery and a matched controlled population who underwent the same operations but who did not die. 34 There were no signi®cant differences between admission systolic and diastolic pressures between the cases and the controls (Fig. 4) . The second was a similar study of emergency surgery; again there were no signi®cant differences between the arterial pressures of the cases and the controls, although in this case there was a tendency for the survivors to have higher admission arterial pressure than those patients who died. 33 While both of these studies suggest that there is no association between admission arterial pressure and perioperative cardiac risk, they are both limited by the fact that most of the patients studied had Stage 1 or Stage 2 hypertension. Few patients with Stage 3 hypertension were studied.
There is very little evidence on which to base the perioperative management of patients who present for surgery with admission arterial pressures consistent with Stage 3 hypertension. Perhaps the best data come from the original study by Prys-Roberts and colleagues. 62 In this study most, if not all, of the hypertensive patients had arterial pressures consistent with Stage 3 hypertension. As already discussed, this study demonstrated increased cardiovascular lability and an increased risk of perioperative myocardial ischaemia in patients with poorly controlled hypertension. It was too small to determine if there was an increased incidence of cardiac events in this population. The evidence from medical studies suggests that patients with Stage 3 hypertension are at signi®cantly increased risk of target organ damage, whether or not this is clinically evident. For example, Stamler and colleagues, and Liao and colleagues demonstrated a steadily increasing incidence of ECG abnormalities in this population. 45 73 There is certainly evidence to support a steadily increasing incidence of postoperative myocardial ischaemia with increasing admission systolic arterial pressure. 31 Many patients with admission arterial pressures consistent with Stage 3 hypertension will have isolated systolic hypertension. There is evidence from the Framingham population of signi®cantly increased cardiovascular risk in this population. Recent analyses suggest that systolic pressure and pulse pressure are more reliable indicators of cardiovascular risk than diastolic pressure. 25 On the basis of these data, we suggest that it is appropriate to defer anaesthesia and surgery where possible in patients with admission arterial pressures consistent with Stage 3 hypertension, especially if there is evidence of target organ damage. However, it must be borne in mind that this recommendation is made on the basis of evidence of risk in medical patients rather than data on perioperative risk. Studies of perioperative risk in patients with Stage 3 hypertension are required.
Isolated systolic hypertension
The steady increase in arterial pressure with age in the Western population is well known. An analysis of data from the Framingham population by Franklin and colleagues has added detail to this picture. 23 They describe a steady increase in systolic arterial pressure starting in childhood and continuing throughout adult life. In contrast, diastolic pressure rises in early adult life and then stabilizes or declines in the ®fth and sixth decade of life. There is a steady rise in pulse pressure throughout adult life and the rate of rise increases after the age of 50 yr. It is against this background that the phenomenon of isolated systolic hypertension has been recognized; that is the situation in which the diastolic arterial pressure is normal, but the systolic arterial pressure is elevated. As might be expected, isolated systolic hypertension accounts for the majority of hypertension in patients over 50 yr old. In the NHANES III data, Franklin and colleagues found that 80% of the subjects aged over 50 yr who had hypertension had isolated systolic hypertension. 24 As a corollary of this, pulse pressure had been found to be strongly associated with cardiovascular risk. 25 The bene®ts of treating isolated systolic hypertension are now clearly established. 29 While the studies of hypertension undertaken by PrysRoberts and colleagues used the then standard de®nition of hypertension of a diastolic arterial pressure of greater than 95 mm Hg, it is clear from their publications that many of their patients had severe systolic hypertension. 59±62 Most later studies that have included an examination of the association between admission arterial pressure and perioperative complications have focused on older patients: for example, in the study by Cooperman and colleagues the average age of the patients was 61 yr; in the study by Eerola and colleagues, 69 of the 111 patients studied were over 60 yr old; and in the study of myocardial re-infarction by Steen and colleagues, 361 of the 466 patients studied were aged 60 yr or over. 13 17 75 It is likely that the majority of poorly controlled hypertensives in these studies had isolated systolic hypertension.
A recent study by Aronson and colleagues examined the association between isolated systolic hypertension and cardiovascular complications in patients undergoing cardiac surgery and these data are worth rehearsing here. This was a prospective study of over 2000 patients in 24 centres undergoing elective cardiac surgery. Patients were classi®ed as having normal preoperative arterial pressure, isolated systolic hypertension (systolic arterial pressure greater than 140 mm Hg), diastolic hypertension (diastolic arterial pressure greater than 90 mm Hg) or a combination of these. After adjusting for other risk factors, isolated systolic hypertension was associated with a small but statistically signi®cant increase in the likelihood of perioperative morbidity (odds ratio 1.3, 95% con®dence interval 1.1± 1.6). 2 The mean systolic arterial pressure of the patients with isolated systolic hypertension is not given, although as the average age of the patients was 65 yr, it is tempting to speculate that it was considerably greater than 140 mm Hg.
It is clear that many of the patients who present for surgery and have arterial pressures consistent with Stage 3 hypertension will be elderly patients with isolated systolic hypertension. There are few if any studies that explicitly examine the impact of isolated systolic hypertension on outcome from non-cardiac surgery and, as with Stage 3 hypertension, work in this area is required. However, the ®ndings of the study by Aronson and colleagues and the work of Franklin and colleagues on the Framingham population do little to reassure the anaesthetist.
White coat hypertension
So-called white coat hypertension is directly relevant to anaesthetic practice. It is formally de®ned as a persistently elevated clinic arterial pressure in combination with a normal ambulatory arterial pressure. 56 Various different arterial pressure thresholds have been used to de®ne white coat hypertension in different studies, leading to con¯icting data as to the prognosis of this condition. 36 Recently, criteria have been agreed and are now widely accepted. These de®ne white coat hypertension as an of®ce arterial pressure of 140/90 mm Hg or greater in the presence of an average daytime reading of less than 135/85 mm Hg. 50 56 Pickering and colleagues highlight the dif®culties in comparing different studies in this area, but suggest that the majority of the data indicate a benign prognosis for white coat hypertension. 56 Kaplan identi®es four prospective studies of the prognosis of hypertension that support this view. 36 38 55 65 80 The largest of these, by Verdecchia and colleagues, followed up 1522 hypertensive subjects for 10 yr. Using a conservative de®nition of white coat hypertension, based on an ambulatory arterial pressure of less than 130/90 mm Hg, this study found the rate of cardiovascular events in white coat hypertension (0.67/100 patient yr) to be little different to that seen in normotensives. 80 It should be noted that when more liberal de®nitions of white coat hypertension, with a higher ambulatory arterial pressure, were used, the cardiovascular event rate in patients with white coat hypertension was close to that of`true' hypertensives. These data suggest that patients who present for elective surgery with admission arterial pressures consistent with Stage 3 hypertension that then settle to levels consistent with normotension may be at less risk of cardiovascular complications than patients with sustained hypertension. However, extrapolating from data derived from a long-term study conducted in the medical setting to draw conclusions about patients undergoing surgery is a leap, and any conclusions drawn have to be treated with some caution.
The various guidelines on the management of hypertension all indicate that the arterial pressure should be measured on a number of occasions over a period of weeks before the diagnosis of hypertension is con®rmed. It is rare for the anaesthetist to have this luxury and often a decision has to be made on perioperative management on the basis of two or three readings taken over a period of hours.
Both doctors and nurses may produce an initial elevation in arterial pressure when they visit a patient, but the effect is greater for doctors than for nurses. This is impressively illustrated by data from Mancia and colleagues. They studied 30 subjects who underwent a 24-h intra-arterial recording after 5±7 days in hospital. During the intra-arterial recording period the arterial pressure was additionally measured at different times using a sphygmomanometer by a male doctor and a female nurse, half of the subjects being randomized to see the doctor ®rst, and the other half the nurse. When the doctor took the ®rst reading, the arterial pressure rose by an average of 22/14 mm Hg. The rises when the ®rst arterial pressure was taken by a nurse were only half as great. The arterial pressure usually returned to near baseline after 10 min when the reading was taken by a nurse, but this was not the case when the pressure was taken by a doctor (Fig. 5) . 47 It is clear from their data that, in many surgical patients, the admission arterial pressure will not equate to the patient's usual arterial pressure. If a member of the medical staff ®nds the patient's arterial pressure to be elevated, this should be con®rmed by a nurse with appropriate training.
Cardiovascular lability
Patients diagnosed as`hypertensive' have a reputation for displaying increased cardiovascular lability during anaesthesia. There is certainly a pathophysiological basis for such behaviour. Established hypertension is associated with an increased systemic vascular resistance. 36 The systemic vasodilatation associated with anaesthesia might well be expected to have profound effects on arterial pressure in such patients. Prys-Roberts and colleagues, and Goldman and Caldera both demonstrated that induction of anaesthesia is associated with a decrease in arterial pressure to a similar nadir in both hypertensive and normotensive patients. 27 62 However, because hypertensive patients in these studies generally had a higher pre-induction arterial pressure, absolute decrease in arterial pressure in these patients was greater. For many anaesthetists, however, cardiovascular lability implies something more than the decrease in arterial pressure seen at induction of anaesthesia. It suggests swings in arterial pressure over a wide range of values, graphically described by Longnecker as`Alpine Anesthesia'. 46 Prys- Roberts and colleagues established that poorly controlled hypertensive patients have a more vigorous cardiovascular response to laryngoscopy and intubation than do normotensives or well controlled hypertensives. 61 Studies by Charleson and colleagues documented swings in arterial pressure in hypertensive and diabetic patients. 7 8 However, their work makes no comparison between hypertensive and normotensive patients in respect to their cardiovascular behaviour, and neither con®rms nor refutes the suggestion that hypertensives are particularly prone to cardiovascular instability. Chung and colleagues examined the association between pre-existing medical conditions and adverse events in 17 638 patients undergoing day-case surgery. 11 They identi®ed an association between pre-existing hypertension and intraoperative cardiovascular events. No major complications, such as death or perioperative infarction, are reported and the majority of these cardiovascular events were episodes of hypertension, although there were also instances of hypotension and arrhythmia. In the largè Multicenter Study of General Anesthesia', it was noted that hypertensive patients were more likely to require interventions for perioperative hypertension. 19 However, the de®n-ition of hypertension used in this study was not given in the report. Taken together, the weight of the evidence is that patients with hypertension may be expected to suffer a greater decrease in arterial pressure at induction of anaesthesia than normotensive patients, although the arterial pressure probably decreases to a similar nadir in both patient groups. The work of Prys-Roberts and colleagues supports a more vigorous response to noxious stimuli in these patients. The ®ndings of Chung and colleagues indicate that patients with pre-existing hypertension frequently have high arterial pressures during the intraoperative period.
11
The clinical impact of wide variations in arterial pressure is dif®cult to quantify, not least because most anaesthetists would not be prepared to leave large changes in arterial pressure untreated for more than a short period of time. Charleson and colleagues reported that, within a high-risk group of hypertensive patients and diabetic patients undergoing elective non-cardiac surgery, those with more than 1 h of a decrease in mean arterial pressure of greater than/equal to 20 mm Hg and those with less than 1 h of a decrease in arterial pressure of greater than/equal to 20 mm Hg and more than 15 min of an increase in arterial pressure of greater than/equal to 20 mm Hg were at greatest risk of complications. 8 In so far as we can tell, the use of vasoactive drugs was allowed in the perioperative period. One has to ask if, in the patients who had wide excursions of arterial pressure, a decision was made not to treat these changes in arterial pressure or if the changes in arterial pressure were refractory to treatment because of ongoing perioperative cardiovascular complications. The association between intraoperative myocardial ischaemia and haemodynamic changes is certainly not clear-cut. In a study of 100 patients who either had, or were at risk for, coronary artery disease, intraoperative ischaemic episodes were preceded by acute increases in arterial pressure in only 15% of episodes and by acute decreases in only 8% of episodes. 48 A recent paper by Reich and colleagues has described an association between intraoperative hypertension and tachycardia and adverse outcome in protracted surgery. 66 It was by no means clear, however, that this was a causal association.
Perioperative management of patients with hypertension or raised arterial pressure
The meta-analysis presented above suggests association between a diagnosis of hypertension and increased perioperative cardiac risk. However, the odds ratio for the effect of hypertension was small and the conclusion must be treated with some circumspection in the light of heterogeneity of the studies examined. There is evidence from many studies that conditions that may represent target organ damage as a result of hypertension contribute to perioperative cardiac risk. A study by Lee and colleagues identi®ed ischaemic heart disease, heart failure, and renal failure as risk factors for perioperative cardiac complications. 42 It would seem sensible to suggest that anaesthetists should pay more heed to the presence of signi®cant target organ damage than to a diagnosis of hypertension per se.
With regard to the management of surgical patients with elevated admission arterial pressure, there are few substantive guidelines over which patients should be cancelled to allow treatment before surgery or the duration of such treatment before proceeding with surgery. The American Heart Association/American College of Cardiology (ACC/ AHA) guidelines comment that hypertension (Stages 1 and 2) is not an independent risk factor for perioperative cardiovascular complications. 15 However, they suggest that Stage 3 hypertension (SAP b180 mm Hg and/or DAP b110 mm Hg) should be controlled before surgery. 15 To quote the guidelines:
In many instances establishment of an effective treatment regimen can be achieved over several days to weeks of preoperative outpatient management. If surgery is more urgent, rapid acting agents can be administered to allow effective control in a matter of minutes or hours. Betablockers appear to be particularly attractive agents. Continuation of preoperative antihypertensive treatment through the perioperative period is critical. ' The observational data presented in this review support the recommendations for Stages 1 and 2 hypertension. The AHA/ACC recommendations for Stage 3 hypertension are not supported by substantial data relating exclusively to patients with arterial pressures greater than 180/110 mm Hg. The best perioperative management of these patients remains unclear. The options available to the anaesthetist are: to ignore the elevated arterial pressure and to continue with anaesthesia and surgery; to institute acute treatment to control the arterial pressure; or to defer surgery for a period of weeks to allow the arterial pressure to be controlled.
High arterial pressures are associated with high levels of after load and cardiac work. This may predispose to myocardial ischaemia and infarction, especially in the presence of coronary artery disease and left ventricular hypertrophy, and therefore simply ignoring markedly elevated arterial pressure may not be appropriate. However, there is evidence that very rapid control of arterial pressure with drugs such as sublingual nifedipine is associated with increased morbidity and mortality. 79 Taken together, these concerns pose the dilemma that markedly raised arterial pressures and wide excursions of arterial pressure should be avoided in the perioperative period, but that dramatic acute reductions in arterial pressure may also be fraught with risk.
Observational data lend weight to these concerns. The work of Charleson and colleagues suggests that excursions in mean arterial pressure of greater than 20% in patients with hypertension and or diabetes are associated with perioperative complications. 8 The work of Gould and colleagues indicates that marked perioperative reductions in arterial pressure may be associated with reduced splanchnic blood¯ow even in the`well ®lled' patient. 28 The best course of action for the anaesthetist would seem to be to defer surgery to allow the arterial pressure to be treated. However, there are no trial data to suggest that this strategy reduces perioperative risk and this advice takes no account of the many issues and problems associated with cancelling an operation within 24 h of surgery. Also, if surgery is deferred to allow the arterial pressure to be treated, it is unclear for how long treatment should be given before the patient returns to have his or her operation.
Weksler and colleagues reported recently the results of a clinical trial in which patients were brought to a waiting room in the operating theatre suite, sedated with midazolam, and had their diastolic pressures measured whilst awaiting surgery. 82 989 patients whose diastolic arterial pressure was between 110 and 130 mm Hg immediately before surgery were entered into the trial. 589 patients were randomized to receive nifedipine 10 mg administered intranasally, while 400 patients were randomized to have their surgery postponed. Those patients in whom surgery was deferred remained in hospital until the diastolic arterial pressure was below 110 mm Hg for at least 3 consecutive days. The frequency of perioperative hypotension and hypertension was similar in the two groups, as was the incidence of tachyarrhythmias and bradyarrhythmias. There were no neurological or cardiovascular complications in either group. This study has a number of weaknesses. It was not blinded, it ran over a 9-yr period, during which many other aspects of patient management could have changed, and systolic hypertension was not studied. However, it offers no support for deferring anaesthesia and surgery to allow the arterial pressure to be treated.
We suggest that, if the patient is considered ®t for surgery in other respects, their operation should not be deferred simply on account of an elevated admission arterial pressure. If the arterial pressure is consistently elevated to levels of 180 mm Hg systolic or greater or 110 mm Hg diastolic or greater, surgery may proceed, but care should be taken to ensure perioperative cardiovascular stability. Invasive arterial pressure monitoring is indicated for major procedures, and the arterial pressure should be actively managed to prevent excursions of the mean arterial pressure of greater than 20% from baseline. Monitoring should continue into the postoperative period until it is clear that the patient is cardiovascularly stable. It may be appropriate to manage the patient in a high dependency area in the immediate postoperative period. In those patients in whom there is no contraindication, perioperative betaadrenergic block may be of value. These drugs are known to reduce perioperative myocardial ischaemia and cardiovascular complications in high-risk patients. 49 57 They carry the additional merit of not producing marked arterial pressure reductions in normotensive subjects. It should be pointed out that Boersma and colleagues have produced observational data that support the widespread use of perioperative beta-adrenergic blockade, but that the available data from randomized controlled trials only provide clear support for their use in high-risk patients with demonstrable new wall motion abnormalities on dobutamine stress echocardiography. 6 32 Clinical trial data to support the use of perioperative beta-adrenergic block in other patients with cardiac disease are awaited. There may be a place for other sympatholytic therapies such as alpha-2 agonists or thoracic epidural block. The pharmacology and use of the alpha-2 agonists has been reviewed by Khan and colleagues. 37 A meta-analysis by Rogers and colleagues suggested that neuroaxial block does offer protection from perioperative myocardial injury. 68 The validity of this ®nding has been challenged and the current position remains unclear. 1 Although Weksler and colleagues reported no problems with intranasal nifedipine administered to 589 patients immediately before surgery, we are unable to recommend its use because of the concerns expressed by Varon and colleagues. 79 82 In making clinical judgements about perioperative management, white coat hypertension is an ever-present problem. If the preoperative arterial pressure is giving cause for concern, several further readings should be obtained by someone who is competent to do so. It seems indefensible to defer planned surgery on the basis of a single arterial pressure reading. In view of the vigorous alerting reaction that can be produced by a visit from a doctor, readings obtained by an experienced nurse may be invaluable. If at all possible, the patient's family doctor should be contacted and enquiry made about arterial pressure readings obtained in the family practitioner's of®ce. It must be a source of irritation for the patient and family doctor for surgery to be deferred and the patient be sent back for treatment of their arterial pressure when the they have been on carefully monitored treatment for months or years and the arterial pressure is known to be well controlled.
Addendum
During the preparation of this review, there has been published the Seventh Report of the Joint National Committee on prevention, detection, evaluation and treatment of high arterial pressure (2003) . This recognizes that the risk of cardiovascular disease begins at a pressure of 115/75 mm Hg and doubles with each increment of 20/10 mm Hg. Individuals with a systolic arterial pressure of 120± 139 mm Hg or diastolic arterial pressure of 80±89 mm Hg should be considered as pre-hypertensive. The JNC VII classi®es arterial pressure in adults as: normal: systolic arterial pressure greater than 120 mm Hg and diastolic arterial pressure less than 80 mm Hg; pre-hypertension: systolic arterial pressure 120±139 mm Hg or diastolic arterial pressure 80±89 mm Hg; Stage I hypertension: systolic arterial pressure 140±159 mm Hg or diastolic arterial pressure 90±99 mm Hg; Stage II hypertension: systolic arterial pressure greater than 160 mm Hg or diastolic arterial pressure greater than 100 mm Hg.
As in previous publications from the JNC, there are no recommendations or guidelines for the perioperative care of the hypertensive patient.
